FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, specifically a method of producing artificial oligonucleotides that are potentially capable of forming non-canonical structures that stable in physiological conditions and conditions close to physiological, said structures being imperfect G-quadruplexes (lmGQ) which include one nucleotide substitution in the G4 plane in the G-quadruplexes (GQ). Said method includes using an algorithm describing nucleotide sequences in form of a defined set of formulae for further synthesis of selected oligonucleotides.
EFFECT: invention enables to use bioinformation analysis to obtain artificial oligonucleotides that are potentially capable of forming a new conformation - imperfect G-quadruplexes.
4 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| COMBINATORIAL METHOD FOR OBTAINING DNA-APTAMER THROMBIN INHIBITORS AND APTAMER OLIGONUCLEOTIDES (VERSIONS) | 2013 | 
 | RU2520094C1 | 
| THROMBIN INHIBITING DNA-APTAMERS AND METHOD OF STRUCTURE STABILISATION | 2009 | 
 | RU2429293C1 | 
| DOSAGE FORM OF DNA-APTAMER | 2019 | 
 | RU2730000C1 | 
| METHOD FOR CONSTRUCTION OF QUADRUPLEX AND METHOD FOR DETECTION OF NUCLEIC ACID | 2002 | 
 | RU2304168C2 | 
| APTAMERS FOR USE IN INHIBITION AND/OR SUPPRESSION OF TLR9 ACTIVATION | 2017 | 
 | RU2789087C2 | 
| TREATMENT OF PROLIFERATIVE DISEASES WITH APPLICATION OF ANTISENSE OLIGOMER IAP AND CHEMOTHERAPEUTICAL PREPARATION | 2004 | 
 | RU2376018C2 | 
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2018 | 
 | RU2795701C2 | 
| DNA APTAMERS TO HUMAN PrimPol PRIMASE AND DNA POLYMERASE | 2020 | 
 | RU2770691C2 | 
| ANTICOAGULANT WITH DIRECT ACTION BASED ON MODULAR BIVALENT DNA OF APTAMER SELECTIVE TO THROMBIN | 2016 | 
 | RU2631829C1 | 
| METHOD FOR DETERMINING SPATIAL STRUCTURE OF BIOMOLECULES | 2020 | 
 | RU2751797C1 | 
Authors
Dates
2014-03-20—Published
2012-10-04—Filed